Equilis Prequenza (Single)
Indicated for the active immunisation of healthy horses and ponies against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection
EQUILIS® PREQUENZA is a vaccine suspension containing per 1ml:
• Purified haemagglutinin/neuraminidase subunits from equine influenza viruses:
- A/equine-1/Prague/1/56 100 AU*
- A/equine-2/Newmarket/1/93 50 AU
- A/equine-2/Newmarket/2/93 50 AU
• Purified saponin (adjuvant) 375 μg
Vaccinate healthy animals only. A transient swelling may occur after vaccination regressing within 2 days. In some cases fever may occur after vaccination. Avoid intravenous injection.
Intramuscular injection of one dose (1 ml) per anima
Basic Vaccination course: All horses not previously vaccinated should receive two vaccinations of one dose with a four week interval. Foals should be vaccinated from the age of six months.
Revaccination: The first revaccination (third dose) is given five months after the basic vaccination course. Revaccination, at 12 month intervals is recommended to maintain immunity levels against equine influenza. Local regulations should be adhered to.
PREGNANCY AND LACTATION:
Can be used in pregnant mares
10 x 1 ml pre-filled syringe with peel-off labels